Exhibit 5.1
May 1, 2020
DuPont de Nemours, Inc.
974 Centre Road
Wilmington, Delaware 19805
Ladies and Gentlemen:
I have acted as counsel for DuPont de Nemours, Inc., a Delaware corporation (the “Company”), in connection with the public offering of $2,000,000,000 aggregate principal amount of the Company’s 2.169% Notes due 2023 (the “Notes”).
In furnishing this opinion, I or a member of my staff have examined and relied upon copies of the Registration Statement on FormS-3 (the “Registration Statement”) filed by the Company on September 5, 2018 with the Securities and Exchange Commission, including the information deemed to be a part of the Registration Statement pursuant to Rule 430B of the General Rules and Regulations under the Securities Act of 1933, as amended, the Second Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws of the Company, as amended to date, the Indenture, dated as of November 28, 2018, between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by the Second Supplemental Indenture dated as of May 1, 2020, between the Company and the Trustee, corporate records of the Company (including certain resolutions of the Board of Directors of the Company (the “Board of Directors”), certain resolutions of the Pricing Committee of the Board of Directors (the “Pricing Committee”), a written consent of a Pricing Officer of the Pricing Committee and minute books of the Company), certificates of public officials and of representatives of the Company, statutes and other instruments and documents as we have deemed necessary or appropriate to form a basis for the opinion hereinafter expressed.